Skip to main content

Table 3 Summary of adverse events

From: A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status

Adverse Events

Total

FDI

Placebo

Infections

5 Infections consisting of one urinary tract infection (UTI); 1 lower respiratory tract infection (LRTI), 1 flu and one exacerbation of chronic obstructive pulmonary disease (eCOPD) and one shingles flare

1 flu

1 UTI,

1 infective

1 eCOPD

1 LRTI

1 shingles

Cardiovascular events

Angina × 2

0

2

Shortness of breath

2

0

2

Other

Hypoglycaemia

Had intravenous fluid for elective CT scan

? lung Cancer

Gout

Depression

Per Rectal bleeding

Acute Kidney Injury episode

Cough

Poor Blood Pressure control

0

0

0

1

1

0

0

1

1

2

1

0

1

0

0

1

1

0

0

0

 

19

in 13 patients

9

in 6 patients

10

in 7 patients